|
CN106946906A
|
|
A kind of compound and its preparation method and application
|
|
CN104892584A
|
|
Amorphous-state Afatinib dimaleate and preparation method and preparation of amorphous-state Afatinib dimaleate
|
|
CN104402895A
|
|
Method for purifying homoharringtonine
|
|
CN104402973A
|
|
Method for preparing carfilzomib amorphous crystal
|
|
CN104356205A
|
|
Method applied to purification of kyprolis
|
|
CN104356197A
|
|
Carfilzomib intermediate and preparation method thereof, as well as preparation method of carfilzomib
|
|
CN103864889A
|
|
Epoxy ketone compound, preparation method thereof and preparation method of kyprolis
|
|
CN103864898A
|
|
Preparation method of kyprolis
|
|
CN103694221A
|
|
Preparation method of pomalyst pomalidomide
|
|
CN103626738A
|
|
Pomalidomide crystal and preparation method thereof
|
|
CN103641890A
|
|
Synthetic method of kyprolis
|
|
CN103626661A
|
|
Compound, and application and preparation method thereof
|
|
CN103613640A
|
|
Bortezomib crystal form J and preparation method thereof
|
|
CN103450303A
|
|
Azacitidine crystal form A and azacitidine crystal form B as well as preparation method thereof
|
|
CN103044364A
|
|
Cabazitaxel amorphous crystal and preparation method thereof
|
|
CN102838586A
|
|
Method for preparing lenalidomide
|
|
CN102746258A
|
|
Crystal forms of cabazitaxel and preparation method thereof
|
|
CN102532065A
|
|
Synthesis method of cabazitaxel
|
|
CN102492021A
|
|
Preparation process for bortezomib
|
|
CN102532064A
|
|
Synthesis method of dimethoxy docetaxel
|
